Moreover, tumor weight significantly decreased in the PCAT18-overexpressed group compared to the control group, while miR-103a-3p mimic management notably counteracted the anti-tumor growth effect produced by PCAT18 overexpression (Figure 6(b)). The gene discussed is PCAT18; the disease is neoplasm.